Dividend Stock Of The Week: Rolls-Royce Reinstates Dividend After 5 Years

Rolls-Royce will recommence dividend payments in June 2025 after announcing positive full year results.

Christopher Johnson 28 February, 2025 | 10:52AM
Facebook Twitter LinkedIn

 

 

Christopher Johnson: One of the UK’s best performing stocks is aerodefense company Rolls Royce.

Its share price soared by 15% on Thursday to 7 pounds and 39 pence, a new record high, after announcing it would restore its dividend payments for the first time since the coronavirus pandemic, after better-than-expected full year results.

Rolls Royce said it will pay a dividend of 6 pence per share which amounts to around 500 million pounds in June 2025.

The company will also undertake a £1 billion share buyback scheme. In total the company will return £1.5 billion to shareholders.

The blue-chip stock, which manufactures fighter jet engines and nuclear reactors for submarines, saw its underlying operating profits jump by 55% in 2024 to £2.5 billion.

Its underlying sales reached £17.8 billion up 15% on levels in 2023.

Meanwhile, Rolls Royce doubled its cash reserves to £2.4 billion.

The UK government’s decision to increase defence spending to 2.5% of GDP may also act as a tailwind for Rolls-Royce, as the UK ups investment in its joint fighter jet programme with Japan and Italy, the AUKUS nuclear partnership with both Australia and the US, and the UK’s nuclear-powered submarine fleet.

Over one year Rolls-Royce is up 102 per cent and its shares are currently trading at £7.50.


The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar's editorial policies.

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn

About Author

Christopher Johnson  is data journalist at Morningstar

© Copyright 2025 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures